Some people experience only mild effects while others need extra support from their prescribing team to manage symptoms
Individuals with insulin resistance or metabolic syndrome may see more pronounced reductions in visceral abdominal fat as tirzepatide improves insulin sensitivity
Oprahs New Special Is a Celebration of Weight-Loss Medication Shame, Blame, and the Weight Loss Revolution , the talk show host and others talk about obesity, medication, and leaving shame behind In Oprah Winfreys newest television special Shame, Blame, and the Weight Loss Revolution, the celebrated television host tells the crowd that when she got over the excitement of first appearing on the cover of TV Guide , she noticed a demeaning headline referencing her weight
This dual action: Enhances appetite suppression Improves insulin sensitivity May produce greater overall metabolic effects What the Research Shows Clinical trials published in The New England Journal of Medicine demonstrate strong outcomes for both medications: Semaglutide: ~14.9% average weight loss over 68 weeks Tirzepatide: up to ~20.9% over 72 weeks While tirzepatide shows higher averages, individual results depend on lifestyle, consistency, and biology